Nivolumab-associated Nasal Polyposis and Eosinophilic Asthma Responsive to Benralizumab, An Anti-IL5R Biologic : Journal of Immunotherapy

Secondary Logo

Journal Logo

Clinical Studies

Nivolumab-associated Nasal Polyposis and Eosinophilic Asthma Responsive to Benralizumab, An Anti-IL5R Biologic

Rembalski, Steven*; Steinberg, Joshua A.*,†

Author Information
Journal of Immunotherapy 45(8):p 370-373, October 2022. | DOI: 10.1097/CJI.0000000000000430

Abstract

You can read the full text of this article if you:

Access through Ovid